Castle Biosciences (Series F)
Funding Details
- Awarder
- Inbox
- Date Award
- July 27, 2015
- Vertical
- Molecular Diagnostics
- Funding URL
- View Funding Page
- Funding Amount:
- $11,700,000
Company Info
- Founding Year
- 2014
- Company Description
- Castle Biosciences is a molecular diagnostics and prognostics company dedicated to helping patients and physicians make optimal decisions regarding treatment and follow-up care based on the tumor's unique molecular signature. The Company currently offers prognostic tests for patients with rare cancers including uveal and cutaneous melanoma, esophageal, thymoma and brain cancers as well as malignant pleural mesothelioma.
- Market
- Healthcare
- Location
- Friendswood, Texas, USA
- Coinvestors
- HealthQuest Capital, Industry Ventures, Mountain Group Capital